mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry
Variants in the IMP2 (insulin-like growth factor 2 [IGF2] mRNA-binding protein 2) gene are implicated in susceptibility to type 2 diabetes. We describe the ability of mammalian target of rapamycin (mTOR) to regulate the cap-independent translation of IGF2 mRNA through phosphorylation of IMP2, an onc...
Main Authors: | Dai, Ning, Rapley, Joseph, Angel, Matthew, Yanik, Mehmet Fatih, Blower, Michael D., Avruch, Joseph |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science |
Format: | Article |
Language: | en_US |
Published: |
Cold Spring Harbor Laboratory Press
2014
|
Online Access: | http://hdl.handle.net/1721.1/88501 |
Similar Items
-
mTOR Signaling in Growth Control and Disease
by: Laplante, Mathieu, et al.
Published: (2014) -
An emerging role of mTOR in lipid biosynthesis
by: Laplante, Mathieu, et al.
Published: (2012) -
mTOR Signaling in Growth, Metabolism, and Disease
by: Saxton, Robert Andrew, et al.
Published: (2018) -
mTOR at the nexus of nutrition, growth, ageing and disease
by: Liu, Grace Y, et al.
Published: (2021) -
mTOR and cancer: many loops in one pathway
by: Efeyan, Alejo, et al.
Published: (2012)